Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Why does it take so much time to get a final USPTO decision?

Net income totaled $9.4 million for the fiscal year ended May 31, 2008, or $0.02 diluted per common share.



thats x pe 8 is 16 cent



Share
New Message
Please login to post a reply